Literature DB >> 15126349

Human CYP1B1 is regulated by estradiol via estrogen receptor.

Yuki Tsuchiya1, Miki Nakajima, Satoru Kyo, Taro Kanaya, Masaki Inoue, Tsuyoshi Yokoi.   

Abstract

Human cytochrome P450 (CYP) 1B1 is a key enzyme in the metabolism of 17beta-estradiol (E2). CYP1B1 is mainly expressed in endocrine-regulated tissues, such as mammary, uterus, and ovary. Because many CYP enzymes are likely to be induced by the substrates themselves, we examined whether the human CYP1B1 expression is regulated by E2 in the present study. Real-time reverse transcription-PCR analysis revealed that treatment with 10 nM E2 for 12 h induced CYP1B1 mRNA expression in estrogen receptor (ER)-positive MCF-7 cells. Luciferase reporter assays using MCF-7 cells showed a significant transactivation up to 7-fold by E2 with a reporter plasmid containing a region from -152 to +25 of the human CYP1B1 gene. A computer-assisted homology search indicated a putative estrogen response element (ERE) between -63 and -49 in the CYP1B1 promoter region. Specific binding of ERalpha to the putative ERE was demonstrated by chromatin immunoprecipitation assays and gel shift analyses. With reporter plasmids containing the wild or mutated putative ERE on the CYP1B1 gene and the wild or mutated ERalpha expression vectors, luciferase assays using Ishikawa cells demonstrated that the putative ERE and ERalpha are essential for the transactivation by E2. Because endometrial tissue is highly regulated by estrogens, the expression pattern of CYP1B1 protein in human endometrial specimens was examined by immunohistochemistry. The staining of CYP1B1 was stronger in glandular epithelial cells during a proliferative phase than those during a secretory phase, consistent with the pattern of estrogen secretion. These findings clearly indicated that the human CYP1B1 is regulated by estrogen via ERalpha. Because 4-hydroxylation of estrogen by CYP1B1 leads to decrease of the estrogenic activity but the produced metabolite is toxicologically active, our findings suggest a clinical significance in the estrogen-regulated CYP1B1 expression for the homeostasis of estrogens as well as estrogen-dependent carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126349     DOI: 10.1158/0008-5472.can-04-0166

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.

Authors:  Shu-Yun Zhang; Sailesh Surapureddi; Sherry Coulter; Stephen S Ferguson; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2012-06-20       Impact factor: 4.436

2.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

3.  Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.

Authors:  Jason Matthews; Björn Wihlén; Jane Thomsen; Jan-Ake Gustafsson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 4.  Corepressors of agonist-bound nuclear receptors.

Authors:  Igor Gurevich; Anthony M Flores; Brian J Aneskievich
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-14       Impact factor: 4.219

5.  The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.

Authors:  Marian Y Williams-Brown; Sana M Salih; Xia Xu; Timothy D Veenstra; Muhammad Saeed; Shaleen K Theiler; Concepcion R Diaz-Arrastia; Salama A Salama
Journal:  J Steroid Biochem Mol Biol       Date:  2011-05-10       Impact factor: 4.292

6.  A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines.

Authors:  Matthew P Dent; Samantha J Madnick; Susan Hall; Marguerite Vantangoli Policelli; Chloe Bars; Hui Li; Ali Amin; Paul L Carmichael; Francis L Martin; Kim Boekelheide
Journal:  Toxicol In Vitro       Date:  2019-05-30       Impact factor: 3.500

7.  A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.

Authors:  Masataka Nakano; Tatsuki Fukami; Saki Gotoh; Miki Nakajima
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

8.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.

Authors:  L M Scott; P Durant; S Leone-Kabler; C E Wood; T C Register; A Townsend; J M Cline
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-08       Impact factor: 4.292

9.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

10.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.